Market Tracker

07/29 12:48pm ET
8.99
Real-Time Quote
 +0.44 / +5.15%
Today’s Change
3.68
Today|||52-Week Range
10.99
+19.31%
Year-to-Date
No recent news for Dyax Corp.

Today’s Trading

Previous close8.55
Today’s open8.58
Day’s range8.58 - 8.96
Volume256,586
Average volume (3 months)1,248,164
Market cap$1.2B
Dividend yield--
Data as of 12:33pm ET, 07/29/2014

Growth & Valuation

Earnings growth (last year)+13.33%
Earnings growth (this year)+24.04%
Earnings growth (next 5 years)+14.94%
Revenue growth (last year)-1.32%
P/E ratioNM
Price/Sales15.17
Price/Book39.53

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...+0.49+8.73%
KERXKeryx Biopharmaceuti...+0.33+2.20%
NKTRNektar Therapeutics+0.20+1.79%
BRLIBio-Reference Labora...-0.09-0.29%
Data as of 12:48pm ET, 07/29/2014

Financials

Last reporting dateJuly 29, 2014
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$53.9M
Annual profit (last year)-$27.8M
Net profit margin-51.51%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gustav A. Christensen
Chief Financial Officer &
Executive Vice President
George V. Migausky
Corporate headquarters
Burlington, Massachusetts

Forecasts